These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35160569)

  • 21. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
    Patel SG; Rajput SJ
    AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrospun Polymer-Free Nanofibers Incorporating Hydroxypropyl-β-cyclodextrin/Difenoconazole via Supramolecular Assembly for Antifungal Activity.
    Gao S; Jiang J; Li X; Ye F; Fu Y; Zhao L
    J Agric Food Chem; 2021 Jun; 69(21):5871-5881. PubMed ID: 34013730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.
    Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
    Eur J Pharm Biopharm; 2010 Feb; 74(2):397-405. PubMed ID: 19944160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
    Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
    Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
    Fernandes CM; Teresa Vieira M; Veiga FJ
    Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
    Mura P; Faucci MT; Bettinetti GP
    Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple complexation of cyclodextrin with soy isoflavones present in an enriched fraction.
    Yatsu FK; Koester LS; Lula I; Passos JJ; Sinisterra R; Bassani VL
    Carbohydr Polym; 2013 Oct; 98(1):726-35. PubMed ID: 23987405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
    Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ternary Inclusion Complexes of Rifaximin with β-Cyclodextrin and Sodium Deoxycholate for Solubility Enhancement.
    Kaur P; Rampal A; Singh Bedi PM; Bedi N
    Curr Drug Discov Technol; 2015; 12(3):179-89. PubMed ID: 26279215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of water-soluble carriers on dissolution characteristics of nifedipine solid dispersions.
    Chutimaworapan S; Ritthidej GC; Yonemochi E; Oguchi T; Yamamoto K
    Drug Dev Ind Pharm; 2000 Nov; 26(11):1141-50. PubMed ID: 11068687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of HPMC concentration on β-cyclodextrin solubilization of norfloxacin.
    Loh GO; Tan YT; Peh KK
    Carbohydr Polym; 2014 Jan; 101():505-10. PubMed ID: 24299805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
    Patel R; Patel M
    Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug.
    Aloisio C; Gomes de Oliveira A; Longhi M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellulose-based matrix microspheres of prednisolone inclusion complex: preparation and characterization.
    Palanisamy M; Khanam J
    AAPS PharmSciTech; 2011 Mar; 12(1):388-400. PubMed ID: 21359603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubility Enhancement of Raloxifene Using Inclusion Complexes and Cogrinding Method.
    Patil PH; Belgamwar VS; Patil PR; Surana SJ
    J Pharm (Cairo); 2013; 2013():527380. PubMed ID: 26555984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes.
    Ansari MT; Batty KT; Iqbal I; Sunderland VB
    Arch Pharm Res; 2011 May; 34(5):757-65. PubMed ID: 21656361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
    Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
    AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.